Tilray Brands Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Brands Inc
LQR LQR House Inc
FCX Freeport-McMoRan Inc
XBIO Xenetic Biosciences Inc
TBCPW Thunder Bridge Capital Partners III Equity Warrant Exp 01 Feb 2025 *W EXP 02/01/2025
HGKGY Power Assets Holdings Ltd
ICPT Intercept Pharmaceuticals Inc
KEY KeyCorp
TTWO Take-Two Interactive Software Inc
TOPS Top Ships Inc
Go

Health Care : Pharmaceuticals | Mid Cap Value
Based in Canada
Company profile

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the cultivation, production, distribution and sale of both medical and adult-use cannabis products. The Distribution business segment is engaged in the purchase and resale of pharmaceutical and wellness products. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage alcohol products. The Wellness business segment is engaged in the production, marketing and distribution of hemp-based food and other wellness products. The Company offers a broad portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, and Bake Sale, among others.

Closing Price
$2.39
Day's Change
0.04 (1.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.42
Day's Low
2.33
Volume
(Light)
Volume:
15,597,650

10-day average volume:
25,807,718
15,597,650

TLRY's position in the Pharmaceuticals industry

Industry PeersTLRYABBVPLSHYCBD

Summary

Company ProfileTilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business...
AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and...
Go to ABBV summary
Panacea Life Sciences Holdings, Inc. is a holding company. The Company is engaged in supporting the life sciences and health and wellness industry. The Company offers remedies within its branded...
Go to PLSH summary
cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium...
Go to YCBD summary
52-Week Change

VS. INDUSTRY
-16.43%
4.44%
128.26%
-90.05%
Market Cap

VS. INDUSTRY
$1.7B
$268.7B
$3.5M
$3.0M
Beta

VS. INDUSTRY
2.4
0.5
4.3
2.0
Dividend Yield

VS. INDUSTRY
--
3.89%
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
--
31.32x
--
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$627.1M
$56.0B
$1.8M
$26.3M
Profit Margin

VS. INDUSTRY
-230.10%
15.52%
-455.64%
-82.47%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
--
13.33%
--
--
Revenue Growth (TTM)

VS. INDUSTRY
-0.20%
-2.31%
-18.54%
-29.55%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.